Condition
Intermediate Risk Prostate Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Intermediate Risk Prostate Cancer clinical trials that are recruiting, at sites in 2 countries (most in United Kingdom (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Androgen-guided PSMA-PET-boost for prostate cancer treated with ADT and SBRT
This study tests whether using PSMA-PET imaging during hormone therapy can help doctors target remaining cancer with a focused SBRT boost in men with intermediate- or high-risk prostate cancer.
-
Reducing prostate cancer treatment from 5 to 3 doses of radiotherapy
This study is testing whether giving fewer doses of radiotherapy for early prostate cancer can still be just as effective and have fewer side effects for patients.
Related topics
Quick answers
How many Intermediate Risk Prostate Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.